Entellus Medical

Investor Relations

We are a medical technology company focused on the design, development and commercialization of products for the minimally invasive treatment of patients in the physician office setting or operating room who are suffering from chronic sinusitis. Our XprESS family of products is used by ear, nose and throat, or ENT, physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation to treat patients with symptomatic inflammation of the nasal sinuses.
Stock Information
ENTL (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$14.13
Change (%) - 0.5 (3.42%)
Volume130,983
Data as of 03/28/17 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
Stock chart for: ENTL.O.  Currently trading at $14.13 with a 52 week high of $22.63 and a 52 week low of $12.31.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Recent NewsMore >>
DateTitle 
02/21/17Entellus Medical Announces Fourth Quarter and Full Year 2016 Financial Results
02/01/17Entellus Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 21, 2017
01/25/17Entellus Medical Announces Pricing of Public Offering of Common Stock
01/25/17Entellus Medical Announces Proposed Public Offering of Common Stock
Upcoming EventsMore >>
There are currently no events scheduled.